THE IMPORTANCE of ongoing investigation
Our Molecular Oncology Laboratory runs innovative translational cancer research programs with the goal of generating a new framework of cancer therapy based on personalized diagnostic models, and incorporating this strategy into daily clinical practice.
R+D Biomarker Discovery
Our aim is to elucidate the role genes play in cancer development and use this knowledge to improve patient care by identifying novel theranostic biomarkers. We focus on validation of new gene signatures predictive of response to adjuvant and neoadjuvant treatment.
Despite advances in recent years with the use of targeted therapies, the prognosis for many cancers remains poor, often due to development of resistance to drugs. Therefore, the development of next-generation cancer therapeutics is a high priority. Thanks to our capabilities in drug discovery and early stage development, we have established collaborations with many leading experts in different fields. We screen new chemical entities obtained from existing libraries of compounds or modelled in silico against the targets of interest to profile activity.